Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Systemic Lupus Erythematosus (SLE)
Clinical trial register · United States · industry-sponsored

Systemic Lupus Erythematosus (SLE) Trials in the USA, 2026

Every industry-sponsored study on the ClinicalTrials.gov registry that lists a US site and is open, about to open, active-but-closed, or enrolling by invitation. This deliberately excludes academic and other non-industry sponsors — the full US registry across all sponsors runs to over 22,000 recruiting studies alone.

Download CSV
Source: ClinicalTrials.gov. Complete coverage of the industry-sponsored slice — all 9175 matching records are in this view (non-industry sponsors are out of scope by design, not truncated). Synced 28 Oct 2026, 03:16 UTC
9175
Studies in scope
industry-sponsored, all four open statuses
4976
Recruiting now
open to new participants
2205
Lead sponsors
across recruiting studies
Top states
California 7 Florida 4 New York 4 Georgia 3 Michigan 3
Narrow the registerReset
Recruitment status
Phase
Target enrolment
to

Systemic Lupus Erythematosus (SLE) trials in the USA

10 of 9175 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
US states
Start
Not yet open
EMD Serono Research & Development Institute, Inc.
Phase 3
404
Massachusetts
2026-10-15
Recruiting
FT839 in Autoimmune Diseases
NCT07800871ANCA-Associated Vasculitis (AAV), Idiopathic Inflammatory Myositis (IIM), Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE)
Fate Therapeutics
Phase 1/2
446
California
2026-10
Recruiting
iCell Gene Therapeutics
Phase 2
20
Illinois, New York, Pennsylvania
2026-09
Recruiting
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
NCT07332481Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE)
EMD Serono Research & Development Institute, Inc.
Phase 3
202
California, Florida, Georgia, Michigan, Texas
2026-03-10
Recruiting
Bristol-Myers Squibb
Phase 4
35
Connecticut, New York, Oklahoma, Tennessee
2026-02-24
Recruiting
Bristol-Myers Squibb
Observational
223
California, Florida, Georgia, Illinois, Maryland, Michigan, Montana, New Jersey
2025-10-08
By invitation
A Phase 1 Study of Prulacabtagene Leucel (Prula-cel, Formerly ADI-001) in Autoimmune Disease
NCT06375993Lupus Nephritis, Autoimmune Diseases, Systemic Sclerosis (SSc), Systemic Lupus Erythematosus (SLE)
Adicet Therapeutics
Phase 1
180
California, New York
2024-11-10
Recruiting
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
NCT06308978Antineutrophilic Cytoplasmic Antibody (ANCA)- Associated Vasculitis (AAV), Idiopathic Inflammatory Myositis (IIM), Systemic Sclerosis (SSc), Systemic Lupus Erythematosus (SLE)
Fate Therapeutics
Phase 1
244
California, Florida, Kentucky, Minnesota, Nebraska, New York, North Carolina, Ohio
2024-03-28
Active, closed
Descartes-08 for Patients With Systemic Lupus Erythematosus
NCT06038474Systemic Lupus Erythematosus (SLE)
Cartesian Therapeutics
Phase 2
6
California
2024-02-12
By invitation
Biogen
Phase 3
864
Arizona, California, Colorado, District of Columbia, Florida, Georgia, Massachusetts, Michigan
2022-06-10
Rows per page Showing 1–10 of 10
1
Cite this view

Priya Life Science (2026). Clinical trial register: industry-sponsored studies with a US investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 28 October 2026. https://priyalifescience.com/clinical-trials-usa/condition/systemic-lupus-erythematosus-sle

Query this register directly
GET /api/trials?country=usa&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every industry-sponsored study on the registry that lists at least one investigative site in the US and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,175 studies in total at the last sync on 28 Oct 2026, 03:16 UTC. Academic and other non-industry sponsors are out of scope by design. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 10 of those studies listing the condition Systemic Lupus Erythematosus (SLE).

How many Systemic Lupus Erythematosus (SLE) trials are recruiting in the US?

6 of the 10 studies on this page are recruiting new participants as of the 28 Oct 2026, 03:16 UTC sync. A further 1 have not yet opened recruitment, 1 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Systemic Lupus Erythematosus (SLE)), 10 studies
PhaseStudiesRecruitingShare
Phase 33130%
Phase 12120%
Phase 22120%
Observational1110%
Phase 1/21110%
Phase 41110%

Most active sponsors

Lead sponsors with the most studies (Systemic Lupus Erythematosus (SLE))
Lead sponsorStudiesRecruiting
Bristol-Myers Squibb22
EMD Serono Research & Development Institute, Inc.21
Fate Therapeutics22
Adicet Therapeutics10
Biogen10
Cartesian Therapeutics10
iCell Gene Therapeutics11

Top states

Top states (Systemic Lupus Erythematosus (SLE)), by number of studies with a site there
StateStudies
California7
Florida4
New York4
Georgia3
Michigan3
Illinois2
Massachusetts2
Arizona1
Colorado1
Connecticut1
Listing here is informational and not medical advice; eligibility is determined by each study team. Compare pay for the teams running these studies in the US Pharma Salary Guide, see who's behind them in the US Company Directory, or track approvals on the FDA Approvals Tracker. For Irish, UK and EU sites, see the Ireland, UK and EU registers.